Yingjie Xu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Coronavirus Disease

Radical Prostatectomy

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Huiyan Sun, Xinxia Wang, Yongqiang Li, Yingzhi Shen, Lin Zhang, Yingjie Xu, Junling Liu, Xuemei Fan
Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy. Pharmaceutics 16 (7) (2024)
Ying Cai, Yun Li, Yingjie Xu, Wen Yang, Masha Huang
TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL-1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (8) (2024)
Huiyan Sun, Xinxia Wang, Yongqiang Li, Yingzhi Shen, Lin Zhang, Yingjie Xu, Junling Liu, Xuemei Fan
Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy. Pharmaceutics 16 (7) (2024)
Huiyan Sun, Xinxia Wang, Yongqiang Li, Yingzhi Shen, Lin Zhang, Yingjie Xu, Junling Liu, Xuemei Fan
Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy. Pharmaceutics 16 (7) (2024)
Ying Cai, Yun Li, Yingjie Xu, Wen Yang, Masha Huang
TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL-1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (8) (2024)
Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu
mRNA-Based Therapeutics in Cancer Treatment. Pharmaceutics 15 (2) (2023)
Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu
mRNA-Based Therapeutics in Cancer Treatment. Pharmaceutics 15 (2) (2023)
Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu
mRNA-Based Therapeutics in Cancer Treatment. Pharmaceutics 15 (2) (2023)
Zhiyin An, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu
The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice. Pharmaceutics 15 (5) (2023)
Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu
mRNA-Based Therapeutics in Cancer Treatment. Pharmaceutics 15 (2) (2023)
Jia Xia, Jiahui Zhang, Liangzhe Wang, Hailong Liu, Jie Wang, Junyan Liu, Zhaoqian Liu, Yingjian Zhu, Yingjie Xu, Wen Yang, Yongjiang Yu
Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation. Cell death & disease 12 (9) (2021)